ARTICLES
Radiosurgery: a new application?
CB Wilson, DA Larson, and PH Gutin
JCO Sep 1 1992: 1373–1374. [PDF]
The late effects of germ cell tumor chemotherapy: more data are needed
GJ Bosl
JCO Sep 1 1992: 1375–1376. [PDF]
	Radiosurgery as part of the initial management of patients with malignant gliomas
	JS Loeffler, E Alexander, 3d, WM Shea, PY Wen, HA Fine, HM Kooy, and PM Black
	JCO Sep 1 1992: 1379–1385. [Abstract] [PDF]
	Hypercholesterolemia after chemotherapy for testis cancer
	D Raghavan, K Cox, A Childs, J Grygiel, and D Sullivan
	JCO Sep 1 1992: 1386–1389. [Abstract] [PDF]
	Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score
	JH Silber, J Radcliffe, V Peckham, G Perilongo, P Kishnani, M Fridman, JW Goldwein, and AT Meadows
	JCO Sep 1 1992: 1390–1396. [Abstract] [PDF]
	Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life
	DM Hays, J Landsverk, SE Sallan, KD Hewett, AF Patenaude, D Schoonover, SL Zilber, K Ruccione, and SE Siegel
	JCO Sep 1 1992: 1397–1406. [Abstract] [PDF]
	No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology
	O Oberlin, JL Habrand, JM Zucker, M Brunat-Mentigny, MJ Terrier-Lacombe, J Dubousset, JC Gentet, C Schmitt, D Ponvert, and C Carrie
	JCO Sep 1 1992: 1407–1412. [Abstract] [PDF]
	Microgranular variant of acute promyelocytic leukemia in children
	A Rovelli, A Biondi, A Cantu Rajnoldi, V Conter, G Giudici, M Jankovic, A Locasciulli, C Rizzari, L Romitti, and MR Rossi
	JCO Sep 1 1992: 1413–1418. [Abstract] [PDF]
	Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study
	SJ Kuerbitz, CI Civin, JP Krischer, Y Ravindranath, CP Steuber, HJ Weinstein, N Winick, AH Ragab, MV Gresik, and WM Crist
	JCO Sep 1 1992: 1419–1429. [Abstract] [PDF]
	Therapy-related acute promyelocytic leukemia: a report on 16 cases
	L Detourmignies, S Castaigne, AM Stoppa, JL Harousseau, A Sadoun, M Janvier, JL Demory, M Sanz, R Berger, and F Bauters
	JCO Sep 1 1992: 1430–1435. [Abstract] [PDF]
	Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients
	K Leitzel, Y Teramoto, E Sampson, J Mauceri, BC Langton, L Demers, E Podczaski, H Harvey, S Shambaugh, and G Volas
	JCO Sep 1 1992: 1436–1443. [Abstract] [PDF]
	Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer
	J Pedersen-Bjergaard, TC Sigsgaard, D Nielsen, SB Gjedde, P Philip, M Hansen, SO Larsen, M Rorth, H Mouridsen, and P Dombernowsky
	JCO Sep 1 1992: 1444–1451. [Abstract] [PDF]
	Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin
	W Brugger, J Frisch, G Schulz, K Pressler, R Mertelsmann, and L Kanz
	JCO Sep 1 1992: 1452–1459. [Abstract] [PDF]
	Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy
	JA Neidhart, A Mangalik, CA Stidley, SL Tebich, LE Sarmiento, JE Pfile, DH Oette, and FB Oldham
	JCO Sep 1 1992: 1460–1469. [Abstract] [PDF]
	Phase I trial of murine monoclonal antibody L6 in combination with subcutaneous interleukin-2 in patients with advanced carcinoma of the breast, colorectum, and lung
	LD Ziegler, P Palazzolo, J Cunningham, M Janus, K Itoh, K Hayakawa, I Hellstrom, KE Hellstrom, C Nicaise, and R Dennin
	JCO Sep 1 1992: 1470–1478. [Abstract] [PDF]
	Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer
	M Markman, B Reichman, T Hakes, JL Lewis, Jr, W Jones, S Rubin, R Barakat, J Curtin, L Almadrones, and W Hoskins
	JCO Sep 1 1992: 1479–1484. [Abstract] [PDF]
	Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study
	M Markman, E Rowinsky, T Hakes, B Reichman, W Jones, JL Lewis, Jr, S Rubin, J Curtin, R Barakat, and M Phillips
	JCO Sep 1 1992: 1485–1491. [Abstract] [PDF]
	Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma
	WI Bensinger, CD Buckner, RA Clift, FB Petersen, JA Bianco, JW Singer, FR Appelbaum, W Dalton, P Beatty, and A Fefer
	JCO Sep 1 1992: 1492–1497. [Abstract] [PDF]
	Systemic chemotherapy of brain metastases from small-cell lung cancer: a review
	CA Kristensen, PE Kristjansen, and HH Hansen
	JCO Sep 1 1992: 1498–1502. [Abstract] [PDF]
Why oncologists burnout
H Kattlove
JCO Sep 1 1992: 1503a. [PDF]
Cisplatin overdosage
IM Pike and MH Arbus
JCO Sep 1 1992: 1503b–1504. [PDF]
Neuropsychologic and neurologic side effects of mitotane and reversibility of symptoms
JB Lanser, AP van Seters, AJ Moolenaar, HR Haak, and EL Bollen
JCO Sep 1 1992: 1504. [PDF]

IN MEMORIAM

William Leo McGuire, MD 1937–1992

C. Kent Osborne

JCO Sep 1 1992: 1377–1378. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	Improved Therapeutic Index of Carboplatin Plus Cyclophosphamide Versus Cisplatin Plus Cyclophosphamide: Final Report by the Southwest Oncology Group of a Phase III Randomized Trial in Stages III and IV Ovarian Cancer
	David S. Alberts, Stephanie Green, Edward V. Hannigan, Robert O'Toole, Donna Stock-Novack, Patricia Anderson, Earl A. Surwit, Vinay K. Malvlya, William A. Nahhas, and Christopher J. Jolles
	JCO Sep 1 1992: 1505. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.